Home › Companies › PROCEPT BioRobotics Corporation › 2025-2026
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and PROCEPT BioRobotics Corporation’s Form 8-K, filed June 10, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 9, 2026: 5 items on PROCEPT BioRobotics Corporation’s Form 8-K, filed June 10, 2026: 3 elected · 2 approved.
Significant dissent: 2 directors (23.0%, 21.1% against).
Notable dissent: 1 say-on-pay vote (73.1% support).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore PROCEPT BioRobotics Corporation in the interactive database Compare manager voting policies
These tallies are PROCEPT BioRobotics Corporation’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 10, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Antal Desai | 28,444,121 | -- | -- | 8,511,185 | 10,418,057 | 77% | Elected | — |
| Elect Director: Mary Garrett | 29,150,610 | -- | -- | 7,804,696 | 10,418,057 | 79% | Elected | — |
| Elect Director: Frederic Moll, M.D. | 36,455,610 | -- | -- | 499,696 | 10,418,057 | 99% | Elected | — |
| 2. Proposal to ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026 | 47,328,539 | -- | 23,133 | 21,691 | -- | 99.9% | Approved | — |
| 3. Proposal to approve, on a non-binding advisory basis, the compensation of the Company's named executive officers | 26,984,867 | -- | 45,735 | 9,924,704 | 10,418,057 | 73% | Approved | — |
Source: PROCEPT BioRobotics Corporation, Form 8-K, filed with the SEC on June 10, 2026 — read the filing on EDGAR.
See voting trends for Health Care companies, 2025-2026: shareholder support by sector and by company size.
273 asset managers disclosed a vote on at least one PROCEPT BioRobotics Corporation item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 4 wordings of this item as funds reported it.
77% Majority: yes · of votes cast
Description as filed by funds: Election of Class II Directors to serve until 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Antal Desai
PROCEPT BioRobotics Corporation’s own tally for this item (“Elect Director: Antal Desai”): 28,444,121 for, 8,511,185 withheld, per its Form 8-K filed June 10, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “All of the nominees for director listed in Proposal 1 in the Company's Definitive Proxy Statement on Schedule 14A, as filed with the Securities and Exchange Commission on April 22, 2026 (the "Proxy Statement"), were elected to serve on the Company's board of directors until the Company's 2029 annua…”
Support: 77% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 69 asset managers below reported 11,365,510 for, 1,227,290 withheld, 39 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,822,031 | 0 | 39 | 0 | For |
| T. Rowe Price | 2,477,773 | 0 | 0 | 0 | For |
| BlackRock | 902,965 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund II | 517,000 | 0 | 0 | 0 | For |
| Charles Schwab | 457,727 | 0 | 0 | 0 | For |
| Global X | 453,685 | 0 | 0 | 0 | For |
| MFS | 0 | 0 | 0 | 425,994 | Withhold |
| JANUS INVESTMENT FUND | 295,038 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 217,744 | 0 | 0 | 0 | For |
| Fidelity | 186,391 | 0 | 0 | 18,470 | Mixed |
| State Street | 147,970 | 0 | 0 | 98 | For |
| WILLIAM BLAIR FUNDS | 0 | 0 | 0 | 146,570 | Withhold |
| TIAA | 121,954 | 0 | 0 | 0 | For |
| Equitable | 81,255 | 0 | 0 | 39,990 | Mixed |
| Federated Hermes | 110,633 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 0 | 0 | 0 | 99,120 | Withhold |
| AllianceBernstein | 0 | 0 | 0 | 86,857 | Withhold |
| Bridge Builder Trust | 66,031 | 0 | 0 | 0 | For |
| VELA Funds | 65,565 | 0 | 0 | 0 | For |
| Jackson National | 0 | 0 | 0 | 56,129 | Withhold |
| Segall Bryant & Hamill Trust | 0 | 0 | 0 | 55,730 | Withhold |
| First Trust | 0 | 0 | 0 | 49,738 | Withhold |
| TRUST FOR PROFESSIONAL MANAGERS | 48,757 | 0 | 0 | 0 | For |
| Lincoln Financial | 36,000 | 0 | 0 | 12,369 | Mixed |
| New York Life | 48,158 | 0 | 0 | 0 | For |
Showing the 25 largest of 69 asset managers. All 69 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: Election of Class II Directors to serve until 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Frederic Moll, M.D.
PROCEPT BioRobotics Corporation’s own tally for this item (“Elect Director: Frederic Moll, M.D.”): 36,455,610 for, 499,696 withheld, per its Form 8-K filed June 10, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “All of the nominees for director listed in Proposal 1 in the Company's Definitive Proxy Statement on Schedule 14A, as filed with the Securities and Exchange Commission on April 22, 2026 (the "Proxy Statement"), were elected to serve on the Company's board of directors until the Company's 2029 annua…”
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 69 asset managers below reported 12,465,991 for, 126,847 withheld, 1 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,822,069 | 0 | 1 | 0 | For |
| T. Rowe Price | 2,477,773 | 0 | 0 | 0 | For |
| BlackRock | 902,965 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund II | 517,000 | 0 | 0 | 0 | For |
| Charles Schwab | 457,727 | 0 | 0 | 0 | For |
| Global X | 453,685 | 0 | 0 | 0 | For |
| MFS | 425,994 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 295,038 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 217,744 | 0 | 0 | 0 | For |
| Fidelity | 204,861 | 0 | 0 | 0 | For |
| State Street | 148,068 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 146,570 | 0 | 0 | 0 | For |
| TIAA | 121,954 | 0 | 0 | 0 | For |
| Equitable | 81,255 | 0 | 0 | 39,990 | Mixed |
| Federated Hermes | 110,633 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 99,120 | 0 | 0 | 0 | For |
| AllianceBernstein | 0 | 0 | 0 | 86,857 | Withhold |
| Bridge Builder Trust | 66,031 | 0 | 0 | 0 | For |
| VELA Funds | 65,565 | 0 | 0 | 0 | For |
| Jackson National | 56,129 | 0 | 0 | 0 | For |
| Segall Bryant & Hamill Trust | 55,730 | 0 | 0 | 0 | For |
| First Trust | 49,738 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 48,757 | 0 | 0 | 0 | For |
| Lincoln Financial | 48,369 | 0 | 0 | 0 | For |
| New York Life | 48,158 | 0 | 0 | 0 | For |
Showing the 25 largest of 69 asset managers. All 69 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
79% Majority: yes · of votes cast
Description as filed by funds: Election of Class II Directors to serve until 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Mary Garrett
PROCEPT BioRobotics Corporation’s own tally for this item (“Elect Director: Mary Garrett”): 29,150,610 for, 7,804,696 withheld, per its Form 8-K filed June 10, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “All of the nominees for director listed in Proposal 1 in the Company's Definitive Proxy Statement on Schedule 14A, as filed with the Securities and Exchange Commission on April 22, 2026 (the "Proxy Statement"), were elected to serve on the Company's board of directors until the Company's 2029 annua…”
Support: 79% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 69 asset managers below reported 11,308,690 for, 1,284,115 withheld, 34 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,819,030 | 0 | 34 | 3,007 | For |
| T. Rowe Price | 2,477,773 | 0 | 0 | 0 | For |
| BlackRock | 902,965 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund II | 517,000 | 0 | 0 | 0 | For |
| Charles Schwab | 457,727 | 0 | 0 | 0 | For |
| Global X | 437,473 | 0 | 0 | 16,212 | For |
| MFS | 0 | 0 | 0 | 425,994 | Withhold |
| JANUS INVESTMENT FUND | 295,038 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 217,744 | 0 | 0 | 0 | For |
| Fidelity | 186,391 | 0 | 0 | 18,470 | Mixed |
| State Street | 147,970 | 0 | 0 | 98 | For |
| WILLIAM BLAIR FUNDS | 0 | 0 | 0 | 146,570 | Withhold |
| TIAA | 121,954 | 0 | 0 | 0 | For |
| Equitable | 81,255 | 0 | 0 | 39,990 | Mixed |
| Federated Hermes | 110,633 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 0 | 0 | 0 | 99,120 | Withhold |
| AllianceBernstein | 0 | 0 | 0 | 86,857 | Withhold |
| Bridge Builder Trust | 66,031 | 0 | 0 | 0 | For |
| VELA Funds | 65,565 | 0 | 0 | 0 | For |
| Jackson National | 0 | 0 | 0 | 56,129 | Withhold |
| Segall Bryant & Hamill Trust | 0 | 0 | 0 | 55,730 | Withhold |
| First Trust | 0 | 0 | 0 | 49,738 | Withhold |
| TRUST FOR PROFESSIONAL MANAGERS | 48,757 | 0 | 0 | 0 | For |
| Lincoln Financial | 36,000 | 0 | 0 | 12,369 | Mixed |
| New York Life | 48,158 | 0 | 0 | 0 | For |
Showing the 25 largest of 69 asset managers. All 69 are in the interactive database (link above).
Combines 11 wordings of this item as funds reported it.
73% Approved · of votes cast
Description as filed by funds: Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers.
PROCEPT BioRobotics Corporation’s own tally for this item (“3. A proposal to approve, on a non-binding advisory basis, the compensation of the Company's named executive officers”): 26,984,867 for, 9,924,704 withheld — passed, per its Form 8-K filed June 10, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 3 in the Proxy Statement, a proposal to approve, on a non-binding advisory basis, the compensation of the Company's named executive officers, was approved by the following vote:”
Support: 73% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,813,933 | 8,137 | 0 | 0 | For |
| T. Rowe Price | 2,399,905 | 77,868 | 0 | 0 | For |
| BlackRock | 847,774 | 55,191 | 0 | 0 | Mixed |
| Advisors' Inner Circle Fund II | 517,000 | 0 | 0 | 0 | For |
| Charles Schwab | 457,727 | 0 | 0 | 0 | For |
| Global X | 437,473 | 16,212 | 0 | 0 | For |
| MFS | 0 | 425,994 | 0 | 0 | Against |
| JANUS INVESTMENT FUND | 295,038 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 0 | 217,744 | 0 | 0 | Against |
| Fidelity | 186,391 | 18,470 | 0 | 0 | Mixed |
| State Street | 147,875 | 193 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 0 | 146,570 | 0 | 0 | Against |
| TIAA | 121,954 | 0 | 0 | 0 | For |
| Equitable | 81,255 | 39,990 | 0 | 0 | Mixed |
| Federated Hermes | 110,633 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 0 | 99,120 | 0 | 0 | Against |
| AllianceBernstein | 0 | 86,857 | 0 | 0 | Against |
| Bridge Builder Trust | 66,031 | 0 | 0 | 0 | For |
| VELA Funds | 65,565 | 0 | 0 | 0 | For |
| Jackson National | 0 | 56,129 | 0 | 0 | Against |
| Segall Bryant & Hamill Trust | 0 | 55,730 | 0 | 0 | Against |
| First Trust | 0 | 49,738 | 0 | 0 | Against |
| TRUST FOR PROFESSIONAL MANAGERS | 0 | 48,757 | 0 | 0 | Against |
| Lincoln Financial | 36,000 | 12,369 | 0 | 0 | Mixed |
| New York Life | 0 | 48,158 | 0 | 0 | Against |
Fund voting reports, all 67 managers: 10,824,567 for, 1,750,166 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 3,800,589 | 77,868 | 0 | 0 | For |
| BNP Paribas Asset Management Holding S.A. | 0 | 3,013,555 | 0 | 0 | Against |
| BlackRock | 1,746,631 | 116,796 | 0 | 0 | Mixed |
| MACKENZIE FINANCIAL CORP | 1,716,294 | 0 | 0 | 0 | For |
| Chicago Capital, LLC | 1,436,659 | 0 | 0 | 0 | For |
| Artisan | 767,192 | 0 | 0 | 0 | For |
| MIROVA | 0 | 729,281 | 0 | 0 | Against |
| Wellington | 635,331 | 0 | 0 | 0 | For |
| Janus Henderson | 622,368 | 0 | 0 | 0 | For |
| State Street | 551,283 | 10,120 | 0 | 0 | For |
| Fiera Capital Corp | 0 | 514,810 | 0 | 0 | Against |
| Bellevue Group AG | 0 | 502,286 | 0 | 0 | Against |
| BAILLIE GIFFORD & CO LTD | 487,434 | 0 | 0 | 0 | For |
| Vanguard | 467,599 | 4,178 | 0 | 0 | For |
| Charles Schwab | 457,738 | 0 | 0 | 0 | For |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 0 | 425,994 | 0 | 0 | Against |
| Champlain Investment Partners, LLC | 404,962 | 0 | 0 | 0 | For |
| C WorldWide Asset Management Fondsmaeglerselskab A/S | 0 | 375,000 | 0 | 0 | Against |
| Northern Trust | 0 | 370,972 | 0 | 0 | Against |
| HSBC | 0 | 305,809 | 0 | 0 | Against |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 0 | 287,939 | 0 | 0 | Against |
| Eagle Health Investments LP | 275,970 | 0 | 0 | 0 | For |
| Prosight Management, LP | 271,276 | 0 | 0 | 0 | For |
| MARSHALL WACE, LLP | 271,234 | 0 | 0 | 0 | For |
| BLAIR WILLIAM & CO/IL | 0 | 268,095 | 0 | 0 | Against |
Institutional-manager reports, all 221 managers: 16,662,554 for, 9,376,884 against, 7,503 abstained, 59,750 not voted. Showing the 25 largest; every one is in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99.9% Approved · of votes cast
Description as filed by funds: Ratification of the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026.
PROCEPT BioRobotics Corporation’s own tally for this item (“2. A proposal to ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026”): 47,328,539 for, 21,691 withheld — passed, per its Form 8-K filed June 10, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2 in the Proxy Statement, a proposal to ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026, was approved by the following vote:”
Support: 99.9% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 69 asset managers below reported 12,592,839 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,822,070 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,477,773 | 0 | 0 | 0 | For |
| BlackRock | 902,965 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund II | 517,000 | 0 | 0 | 0 | For |
| Charles Schwab | 457,727 | 0 | 0 | 0 | For |
| Global X | 453,685 | 0 | 0 | 0 | For |
| MFS | 425,994 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 295,038 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 217,744 | 0 | 0 | 0 | For |
| Fidelity | 204,861 | 0 | 0 | 0 | For |
| State Street | 148,068 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 146,570 | 0 | 0 | 0 | For |
| TIAA | 121,954 | 0 | 0 | 0 | For |
| Equitable | 121,245 | 0 | 0 | 0 | For |
| Federated Hermes | 110,633 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 99,120 | 0 | 0 | 0 | For |
| AllianceBernstein | 86,857 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 66,031 | 0 | 0 | 0 | For |
| VELA Funds | 65,565 | 0 | 0 | 0 | For |
| Jackson National | 56,129 | 0 | 0 | 0 | For |
| Segall Bryant & Hamill Trust | 55,730 | 0 | 0 | 0 | For |
| First Trust | 49,738 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 48,757 | 0 | 0 | 0 | For |
| Lincoln Financial | 48,369 | 0 | 0 | 0 | For |
| New York Life | 48,158 | 0 | 0 | 0 | For |
Showing the 25 largest of 69 asset managers. All 69 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 56,897,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 8.48% |
| 2 | T. Rowe Price | 4.35% |
| 3 | BlackRock | 1.59% |
| 4 | Advisors' Inner Circle Fund II | 0.91% |
| 5 | Charles Schwab | 0.80% |
| 6 | Global X | 0.80% |
| 7 | MFS | 0.75% |
| 8 | JANUS INVESTMENT FUND | 0.52% |
| 9 | WASATCH FUNDS TRUST | 0.38% |
| 10 | Fidelity | 0.36% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | T. Rowe Price | 6.82% |
| 2 | BNP Paribas Asset Management Holding S.A. | 5.30% |
| 3 | BlackRock | 3.28% |
| 4 | MACKENZIE FINANCIAL CORP | 3.02% |
| 5 | Chicago Capital, LLC | 2.53% |
| 6 | Artisan | 1.35% |
| 7 | MIROVA | 1.28% |
| 8 | Wellington | 1.12% |
| 9 | Janus Henderson | 1.09% |
| 10 | State Street | 0.99% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| BlackRock | 4,362,002 | 7.67% | Form 13F, quarter ended March 31, 2026 |
| BNP Paribas Asset Management Holding S.A. | 3,094,649 | 5.44% | Schedule 13G, filed February 11, 2026 |
| Reza Zadno, Ph.D. | 1,677,642 | 2.95% | Proxy statement (DEF 14A), table as of April 10, 2026 |
| State Street | 1,529,631 | 2.69% | Form 13F, quarter ended March 31, 2026 |
| FMR (Fidelity) | 1,461,904 | 2.57% | Form 13F, quarter ended March 31, 2026 |
| Point72 | 1,139,943 | 2.00% | Form 13F, quarter ended March 31, 2026 |
| Frederic Moll, M.D. | 952,163 | 1.67% | Proxy statement (DEF 14A), table as of April 10, 2026 |
| Wellington Management | 861,605 | 1.51% | Form 13F, quarter ended March 31, 2026 |
| Morgan Stanley | 843,491 | 1.48% | Form 13F, quarter ended March 31, 2026 |
| T. Rowe Price | 605,958 | 1.07% | Form 13F, quarter ended March 31, 2026 |
Percentages above are of 56,897,000 shares outstanding, as reported by PROCEPT BioRobotics Corporation on its Form 10-Q dated March 31, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At PROCEPT BioRobotics Corporation's shareholder meeting held June 9, 2026, in the 2025-2026 proxy season, 273 asset managers reported votes on at least one of its 5 ballot items in their SEC Form N-PX filings, covering 1,309 separate fund positions. On the most widely held item on that ballot — Approval, on a non-binding advisory basis, of the compensation of the Company's named executive… — PROCEPT BioRobotics Corporation's filing reports the proposal as approved, with 73% support of the votes cast (FOR divided by FOR plus WITHHELD, because this ballot offered only for and withhold; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: PROCEPT BioRobotics Corporation's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 10, 2026.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from PROCEPT BioRobotics Corporation’s 10-Q dated March 31, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
PROCEPT BioRobotics Corporation proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Proxy Votes Now, “PROCEPT BioRobotics (PRCT) 2026 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/procept-biorobotics-corp/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.